Karyopharm Therapeutics Inc. SEC filings KPTI

Karyopharm Therapeutics Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Apr 2, 2015. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (listing notice). The company's fiscal year ends on December 31.

Karyopharm Therapeutics Inc. SEC filings
Form Description Filed Period
8-K Current report
Listing notice
Nov 5, 2026 Nov 4, 2026
8-K Current report
Material agreement, Bankruptcy, New debt, Regulation FD disclosure, Other events
Nov 3, 2026 Nov 2, 2026
8-K Current report
Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
8-K Current report
Other events
Oct 22, 2026 Oct 22, 2026
8-K Current report
Other events
Oct 14, 2026 Oct 13, 2026
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 18, 2026 Sep 17, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 11, 2026 Sep 10, 2026
8-K Current report
Other events
Aug 31, 2026 Aug 31, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Other events
Jul 31, 2026 Jul 30, 2026
8-K Current report
Officer or director change
Jul 17, 2026 Jul 13, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2026 May 21, 2026
S-8 Employee stock plan registration May 27, 2026 —
S-8 Employee stock plan registration May 27, 2026 —
EFFECT Filing May 14, 2026 —
EFFECT Filing May 14, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
CORRESP Letter to the SEC May 12, 2026 —
CORRESP Letter to the SEC May 12, 2026 —
UPLOAD Letter from the SEC May 7, 2026 —
UPLOAD Letter from the SEC May 7, 2026 —
S-3 Shelf registration May 4, 2026 —
S-3 Shelf registration May 4, 2026 —
ARS Annual report to shareholders Apr 13, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 13, 2026 Apr 13, 2026
8-K Current report
Other events
Mar 27, 2026 Mar 27, 2026
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Mar 24, 2026 Mar 24, 2026
8-K Current report
Material agreement, Other events
Mar 3, 2026 Feb 27, 2026
8-K Current report
Shareholder vote results
Feb 19, 2026 Feb 18, 2026
10-K Annual report Feb 13, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 12, 2026 Feb 12, 2026
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
DEF 14A Proxy statement Jan 9, 2026 Feb 18, 2026
PRE 14A Preliminary proxy statement Dec 30, 2025 Dec 30, 2025
424B3 Prospectus Nov 24, 2025 —
424B3 Prospectus Nov 24, 2025 —
S-3 Shelf registration Nov 3, 2025 —
S-3 Shelf registration Nov 3, 2025 —
10-Q Quarterly report Nov 3, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 3, 2025 Nov 3, 2025
8-K Current report
Material agreement, New debt, Other events
Oct 14, 2025 Oct 10, 2025
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Oct 8, 2025 Oct 7, 2025
8-K Current report
Officer or director change
Sep 11, 2025 Sep 5, 2025
S-8 Employee stock plan registration Aug 11, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Regulation FD disclosure
Jul 11, 2025 Jul 11, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 29, 2025 May 28, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 14, 2025 —
DEF 14A Proxy statement Apr 14, 2025 May 28, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Feb 24, 2025 Feb 24, 2025
10-K Annual report Feb 19, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 19, 2025 Feb 19, 2025
8-K Current report
Officer or director change
Jan 31, 2025 Jan 27, 2025
8-K Current report
Shareholder vote results
Jan 30, 2025 Jan 30, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change
Jan 2, 2025 Jan 2, 2025
DEF 14A Proxy statement Dec 16, 2024 Jan 30, 2025
PRE 14A Preliminary proxy statement Dec 5, 2024 Dec 5, 2024
8-K Current report
Regulation FD disclosure
Dec 3, 2024 Dec 3, 2024
8-K Current report
Officer or director change
Nov 20, 2024 Nov 20, 2024
8-K Current report
Material agreement
Nov 8, 2024 Nov 5, 2024
S-8 Employee stock plan registration Nov 5, 2024 —
10-Q Quarterly report Nov 5, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 5, 2024 Nov 5, 2024
8-K Current report
Regulation FD disclosure, Other events
Oct 31, 2024 Oct 31, 2024
8-K Current report
Listing notice
Sep 17, 2024 Sep 16, 2024
8-K Current report
Officer or director change
Aug 29, 2024 Aug 26, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
SC TO-I/A Filing Jul 19, 2024 —
SC TO-I Filing Jun 20, 2024 —
EFFECT Filing Jun 7, 2024 —
CORRESP Letter to the SEC Jun 5, 2024 —
UPLOAD Letter from the SEC Jun 3, 2024 —
8-K Current report
Officer or director change, Shareholder vote results
May 31, 2024 May 29, 2024
S-3 Shelf registration May 30, 2024 —
S-8 Employee stock plan registration May 30, 2024 —
8-K Current report
Other events
May 14, 2024 May 13, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
May 8, 2024 May 8, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
ARS Annual report to shareholders Apr 19, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 19, 2024 —
DEF 14A Proxy statement Apr 19, 2024 May 29, 2024
UPLOAD Letter from the SEC Apr 18, 2024 —
SC TO-C Filing Apr 8, 2024 —
PRE 14A Preliminary proxy statement Apr 8, 2024 May 29, 2024
CORRESP Letter to the SEC Apr 3, 2024 —
UPLOAD Letter from the SEC Mar 21, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 29, 2024 Feb 29, 2024
8-K Current report
Other events
Feb 20, 2024 Feb 16, 2024
8-K Current report
Results of operations
Jan 8, 2024 Jan 8, 2024
8-K Current report
Listing notice
Dec 12, 2023 Dec 6, 2023
8-K Current report
Officer or director change
Dec 8, 2023 Dec 5, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 2, 2023 Nov 2, 2023
8-K Current report
Officer or director change
Sep 1, 2023 Aug 31, 2023
S-8 Employee stock plan registration Aug 2, 2023 —
10-Q Quarterly report Aug 2, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 2, 2023 Aug 2, 2023
8-K Current report
Officer or director change, Shareholder vote results
May 25, 2023 May 24, 2023
EFFECT Filing May 5, 2023 —
10-Q Quarterly report May 4, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 4, 2023 May 4, 2023
CORRESP Letter to the SEC May 3, 2023 —
ARS Annual report to shareholders Apr 11, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 11, 2023 —
DEF 14A Proxy statement Apr 11, 2023 —
PRE 14A Preliminary proxy statement Mar 31, 2023 —
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
UPLOAD Letter from the SEC Feb 21, 2023 —
S-3 Shelf registration Feb 17, 2023 —
S-8 Employee stock plan registration Feb 17, 2023 —
10-K Annual report Feb 17, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Feb 15, 2023 Feb 9, 2023
8-K Current report
Results of operations
Feb 15, 2023 Feb 15, 2023
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
EFFECT Filing Jan 3, 2023 —
CORRESP Letter to the SEC Dec 29, 2022 —
UPLOAD Letter from the SEC Dec 28, 2022 —
S-3 Shelf registration Dec 23, 2022 —
8-K Current report
Other events
Dec 14, 2022 Dec 10, 2022
D Filing Dec 8, 2022 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Dec 5, 2022 Dec 5, 2022
8-K Current report
Bylaw or fiscal year change
Dec 2, 2022 Dec 2, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
8-K Current report
Officer or director change
Jul 28, 2022 Jul 26, 2022
8-K Current report
Agreement ended
Jun 15, 2022 Jun 7, 2022
S-8 Employee stock plan registration Jun 3, 2022 —
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2022 May 19, 2022
DEFA14A Additional proxy material May 12, 2022 —
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 8, 2022 —
DEF 14A Proxy statement Apr 8, 2022 May 19, 2022
8-K Current report
Officer or director change
Mar 29, 2022 Mar 28, 2022
8-K Current report
Officer or director change
Mar 28, 2022 Mar 22, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
S-8 Employee stock plan registration Feb 28, 2022 —
8-K Current report
Results of operations, Other events
Feb 8, 2022 Feb 8, 2022
8-K Current report
Results of operations
Jan 10, 2022 Jan 10, 2022
8-K Current report
Material agreement
Dec 21, 2021 Dec 17, 2021
8-K Current report
Regulation FD disclosure
Dec 8, 2021 Dec 8, 2021
8-K Current report
Officer or director change
Dec 6, 2021 Dec 2, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 3, 2021 Nov 3, 2021
S-8 Employee stock plan registration Aug 5, 2021 —
S-3ASR Automatic shelf registration Aug 5, 2021 —
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
CT ORDER Filing Jul 13, 2021 —
8-K Current report
Material agreement
Jun 24, 2021 Jun 23, 2021
8-K Current report
Shareholder vote results
May 24, 2021 May 21, 2021
10-Q Quarterly report May 4, 2021 Mar 31, 2021
DEFA14A Additional proxy material May 3, 2021 —
8-K Current report
Results of operations
May 3, 2021 May 3, 2021
8-K Current report
Officer or director change
May 3, 2021 Apr 27, 2021
CT ORDER Filing Apr 19, 2021 —
DEFA14A Additional proxy material Apr 7, 2021 —
DEF 14A Proxy statement Apr 7, 2021 May 21, 2021
S-8 Employee stock plan registration Feb 24, 2021 —
10-K Annual report Feb 24, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 11, 2021 Feb 11, 2021
8-K Current report
Results of operations
Jan 11, 2021 Jan 11, 2021
8-K Current report
Other events
Dec 18, 2020 Dec 18, 2020
8-K Current report
Bylaw or fiscal year change
Dec 17, 2020 Dec 16, 2020
8-K Current report
Officer or director change
Dec 1, 2020 Nov 25, 2020
10-Q Quarterly report Nov 2, 2020 Sep 30, 2020
8-K Current report
Results of operations, Other events
Nov 2, 2020 Nov 2, 2020
8-K Current report
Officer or director change
Sep 25, 2020 Sep 23, 2020
8-K Current report
Officer or director change
Aug 31, 2020 Aug 25, 2020
S-8 Employee stock plan registration Aug 4, 2020 —
10-Q Quarterly report Aug 4, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 4, 2020 Aug 4, 2020
8-K Current report
Results of operations
Jul 14, 2020 Jul 14, 2020
8-K Current report
Other events
Jun 22, 2020 Jun 22, 2020
8-K Current report
Shareholder vote results
May 26, 2020 May 21, 2020
424B5 Prospectus supplement May 5, 2020 —
8-K Current report
Material agreement
May 5, 2020 May 5, 2020
10-Q Quarterly report May 5, 2020 Mar 31, 2020
8-K Current report
Material agreement, Results of operations
May 5, 2020 May 1, 2020
DEFA14A Additional proxy material Apr 9, 2020 —
DEF 14A Proxy statement Apr 9, 2020 May 21, 2020
S-8 Employee stock plan registration Mar 13, 2020 —
8-K Current report
Material agreement, Other events
Mar 4, 2020 Mar 3, 2020
424B5 Prospectus supplement Mar 4, 2020 —
424B5 Prospectus supplement Mar 2, 2020 —
8-K Current report
Other events
Mar 2, 2020 Mar 2, 2020
8-K Current report
Officer or director change
Feb 28, 2020 Feb 26, 2020
S-3ASR Automatic shelf registration Feb 26, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KPTI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Newton, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1503802

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.